Published in Neurology on August 17, 2011
Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol (2015) 1.86
Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry (2012) 1.34
Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends Neurosci (2013) 1.29
Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology. Nat Rev Neurol (2012) 0.99
GroupICA dual regression analysis of resting state networks in a behavioral variant of frontotemporal dementia. Front Hum Neurosci (2013) 0.94
Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia. Neurology (2013) 0.93
Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol (2013) 0.92
Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain (2014) 0.89
Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders. Mol Psychiatry (2014) 0.87
Reduced functional brain connectivity prior to and after disease onset in Huntington's disease. Neuroimage Clin (2013) 0.87
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. Front Aging Neurosci (2015) 0.87
Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease. Front Hum Neurosci (2015) 0.80
Selectively Disrupted Functional Connectivity Networks in Type 2 Diabetes Mellitus. Front Aging Neurosci (2015) 0.79
Recent advances in the imaging of frontotemporal dementia. Curr Neurol Neurosci Rep (2012) 0.78
Affective mentalizing and brain activity at rest in the behavioral variant of frontotemporal dementia. Neuroimage Clin (2015) 0.76
Presymptomatic studies in genetic frontotemporal dementia. Rev Neurol (Paris) (2013) 0.76
The Effect of Gray Matter ICA and Coefficient of Variation Mapping of BOLD Data on the Detection of Functional Connectivity Changes in Alzheimer's Disease and bvFTD. Front Hum Neurosci (2017) 0.75
Functional connectivity and microstructural white matter changes in phenocopy frontotemporal dementia. Eur Radiol (2016) 0.75
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy. Neurobiol Aging (2016) 0.75
Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. Neuroimage Clin (2016) 0.75
Sustained synchronized neuronal network activity in a human astrocyte co-culture system. Sci Rep (2016) 0.75
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A (2005) 37.57
Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A (2002) 31.14
Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci (2007) 27.23
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci (2007) 19.58
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68
Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging (2004) 14.60
Intrinsic functional connectivity as a tool for human connectomics: theory, properties, and optimization. J Neurophysiol (2009) 9.94
Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69
Disruption of large-scale brain systems in advanced aging. Neuron (2007) 8.12
DPARSF: A MATLAB Toolbox for "Pipeline" Data Analysis of Resting-State fMRI. Front Syst Neurosci (2010) 7.69
A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks. Proc Natl Acad Sci U S A (2008) 7.54
Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex (2007) 5.28
Correlations and anticorrelations in resting-state functional connectivity MRI: a quantitative comparison of preprocessing strategies. Neuroimage (2009) 4.88
Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain (2010) 3.84
Patterns of brain activity supporting autobiographical memory, prospection, and theory of mind, and their relationship to the default mode network. J Cogn Neurosci (2010) 2.77
Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol (2008) 2.51
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain (2008) 2.13
Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain (2009) 1.93
High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet (1999) 1.87
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology (2009) 1.48
Inheritance of frontotemporal dementia. Arch Neurol (1999) 1.34
Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology (2009) 1.28
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? Neurology (2010) 1.25
Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology (2009) 1.16
Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch Neurol (2008) 1.13
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann Neurol (1992) 1.11
Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord (2006) 1.09
Distribution of brain atrophy in behavioral variant frontotemporal dementia. J Neurol Sci (2005) 1.02
In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: a PET and MRI study. Parkinsonism Relat Disord (2010) 0.96
Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier. J Neurol Neurosurg Psychiatry (2004) 0.96
Semantic memory involvement in the default mode network: a functional neuroimaging study using independent component analysis. Neuroimage (2010) 0.94
MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology. Neurology (2010) 0.92
Theory of mind in frontotemporal dementia. Soc Neurosci (2006) 0.92
Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family. Neurology (1996) 0.78
CATH--a hierarchic classification of protein domain structures. Structure (1997) 29.95
The PSIPRED protein structure prediction server. Bioinformatics (2000) 20.58
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82
Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol (2004) 10.13
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology (2009) 7.04
Acetone-butanol fermentation revisited. Microbiol Rev (1986) 6.55
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 6.12
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol (1997) 6.02
A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. JAMA (1994) 5.98
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology (2004) 5.86
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Protein superfamilies and domain superfolds. Nature (1994) 5.11
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology (2005) 5.02
Eijkman Relationships of the Coliform and Related Bacteria. J Bacteriol (1942) 4.94
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology (1992) 4.87
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology (2004) 4.74
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain (2009) 4.51
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology (2008) 4.31
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 4.31
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
Antigenic Relationships of the Coliform Bacteria. J Bacteriol (1940) 4.11
Phenotypic correlations in FTDP-17. Neurobiol Aging (2001) 3.96
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology (2000) 3.84
Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology (2010) 3.83
Protein annotation and modelling servers at University College London. Nucleic Acids Res (2010) 3.77
Enhancing the educational content of SHO posts. BMJ (1993) 3.75
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
Cognitive impairment in hemodialysis patients is common. Neurology (2006) 3.68
Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med (1993) 3.65
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology (2006) 3.60
The short test of mental status. Correlations with standardized psychometric testing. Arch Neurol (1991) 3.45
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology (2004) 3.41
Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology (2011) 3.30
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology (2007) 3.24
Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology (2005) 3.21
Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12
The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology (2012) 3.01
Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction. Stroke (1993) 2.98
Organ motion and its management. Int J Radiat Oncol Biol Phys (2001) 2.96
Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology (2007) 2.93
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology (2003) 2.88
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83
Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science (1991) 2.81
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology (1999) 2.81
Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain (2000) 2.76
'Ending up a GP': a qualitative study of junior doctors' perceptions of general practice as a career. Fam Pract (1997) 2.70
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69